New online course aims to help chronic patients take control of their health
NCT ID NCT07367750
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a 6-week online program called the Chronic Disease Self-Management Program (CDSMP) for people in Israel living with a kidney transplant or cancer. The program teaches practical skills like managing symptoms, setting health goals, and communicating with doctors. Researchers will survey 45 participants before, after, and 6 months later to see if it improves confidence and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Chronic Disease Self-Management Program (CDSMP) - a structured, peer-led online course
- What this could lead to
- If it works, this could provide a practical, low-cost way to help people with chronic conditions feel more in control and improve their daily well-being.
- What could go wrong
- This is a small feasibility study with only 45 participants, so results may not apply broadly. The program is behavioral, not a medical treatment, and benefits may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 45 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 21 years or older * Diagnosed with at least one chronic disease (as documented in the medical record) * Community-dwelling * Fluent in Hebrew Exclusion Criteria: * Documented cognitive impairment * Diagnosis of major depression or other psychiatric disorder (based on self-report or medical records) * Hospitalization in the past 3 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Tel Aviv Sourasky Medical Center
RECRUITINGTel Aviv, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a nurse and a neighbor help tame chronic disease?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Can a heart drug shield transplant patients from their own medications?
- Two-Drug combo aims to stall advanced breast cancer